Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$3.92−0.08 (-2.00%)

Close on Nov 13, 2026Market cap $50.37MP/E –Yield –

Clene statistics

76 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 11, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $50.37M; $272.32M
Enterprise Value: $41.43M; $146.23M
PS Ratio: 211.62; 3.66

Enterprise valuationIndustry

EV / Sales: 174.08; 2.57

Share statisticsIndustry

Shares Outstanding: 13M; 58M
Shares Change (YoY): 33.6%; 10.8%
Shares Change (QoQ): 11.2%; 0.50%
Float: 7M; 49M
Shares Held by Insiders: 45.9%; 11.7%
Shares Held by Institutions: 24.8%; 56.4%

Short sellingIndustry

Short Interest: 416,980; –
Short Interest Change: -1.86%; -0.80%
Short % of Float: 5.99%; 9.01%
Short % of Shares Outstanding: 3.25%; 6.30%
Days to Cover: 5.06; 5.15

Stock price statisticsIndustry

52-Week High: $10.84; –
52-Week Low: $3.02; –
20-Day Moving Average: $3.92; –
50-Day Moving Average: $3.90; –
200-Day Moving Average: $5.13; –
Average True Range (14): $0.39; –
Price Change (1 Week): -0.76%; -1.15%
Price Change (1 Month): 18.6%; -4.87%
Price Change (3 Months): -6.67%; -21.0%
Price Change (6 Months): -45.1%; -20.6%
Price Change (YTD): -33.2%; -23.6%
Price Change (1 Year): -58.3%; -22.4%
Price Change (3 Years): -55.5%; -29.5%
Price Change (5 Years): -96.4%; -77.9%
Average Volume (10 Days): 108,564; –
Average Volume (20 Days): 89,855; –
Average Volume (90 Days): 98,460; –
Relative Volume: 0.29; 0.70
Relative Strength Index (14): 49.1; 43.4
Volatility (1 Year): 94.9%; 80.1%
Beta (5 Years): 0.79; 1.07

MarginsIndustry

Gross Margin: 68.5%; 53.1%
Operating Margin: -8928.6%; -38.7%
Pretax Margin: -11271.4%; -11.6%
Profit Margin: -11271.4%; -31.6%
EBITDA Margin: -8928.6%; -27.7%

Returns on capitalIndustry

Return on Assets (ROA): -120.7%; -40.6%
Return on Capital Employed (ROCE): -421.4%; -37.9%

Financial positionIndustry

Current Ratio: 0.85; 3.30
Quick Ratio: 0.58; 2.39
Interest Coverage: -7.34; -6.35

GrowthIndustry

Revenue Growth (YoY): 11.2%; 6.82%
Revenue Growth (3Y CAGR): -24.9%; 2.25%
Revenue Growth (5Y CAGR): -0.59%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.01; 0.40
Inventory Turnover: 1.47; 2.73
Revenue Per Employee: $3.01K; $429.29K
Profits Per Employee: -$339.57K; -$689.41K
Employee Count: 79; 74
WACC: 9.09%; 10.2%

Income statement (TTM)Industry

Revenue: $238.00K; $66.37M
Gross Profit: $163.00K; $120.78M
Operating Income: -$21.25M; -$21.37M
Pretax Income: -$26.83M; -$12.95M
Net Income: -$26.83M; -$22.35M
EBITDA: -$21.25M; -$17.21M
EPS (Diluted): -$2.58; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $9.90M; $68.68M
Total Debt: $964.00K; $116.91M
Net Cash (Debt): $8.94M; $17.76M
Net Cash Per Share: $0.70; $0.80
Equity (Book Value): -$14.81M; $53.89M
Book Value Per Share: -$1.15; $1.50
Tangible Book Value: -$14.81M; $27.13M
Working Capital: -$2.62M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$16.53M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -53.3%; -21.8%

Taxes and interestIndustry

Interest Expense: $2.90M; $2.90M
Income Tax: $0; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -23.07; 0.23
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CLNN	S&P 500	Difference	CLNN per year	S&P 500 per year
1 month	+15.6%	-3.0%	+18.7 pts
3 months	-6.4%	-2.8%	−3.7 pts
Year to date	-33.2%	+11.5%	−44.7 pts
1 year	-46.3%	+13.5%	−59.8 pts
3 years	-58.2%	+77.7%	−135.9 pts	-25.3%	+21.1%
5 years	-96.4%	+72.6%	−169.0 pts	-48.6%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M CLNN shares were sold short on Oct 30, 2026, down 1.9% from the previous report, or 5.99% of the shares available to trade. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 31.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	416,980	-1.9%	82,334	5.1
Oct 15, 2026	424,864	-51.8%	94,981	4.5
Sep 30, 2026	880,688	-3.8%	117,415	7.5
Sep 15, 2026	915,634	-5.2%	177,656	5.2
Aug 31, 2026	965,618	-4.2%	54,676	17.7
Aug 14, 2026	1,008,389	+6.4%	105,094	9.6
Jul 31, 2026	947,551	+2.4%	65,651	14.4
Jul 15, 2026	925,388	-6.4%	50,232	18.4
Jun 30, 2026	988,908	-6.4%	101,618	9.7
Jun 15, 2026	1,056,263	-6.1%	102,124	10.3
May 29, 2026	1,125,471	-14.9%	117,109	9.6
May 15, 2026	1,322,944	+51.2%	2,256,674	1.0